Jentashapir Journal of Health Research

Published by: Kowsar

The Five-Year Survival of Patients With Endometrioid-Type Endometrial Cancer

Fatemeh Cheraghi 1 , * , Mitra Modaress Gilani 2 , Fatemeh Ghaemmaghami 2 and Azamsadat Mousavi 2
Authors Information
1 Fertility, Infertility and Perinatology Research Center, Imam Khomeini Hospital, Medicine Faculty, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jentashapir Journal of Health Research: December 2015, 6 (6); e28714
  • Published Online: December 14, 2015
  • Article Type: Research Article
  • Received: March 15, 2015
  • Accepted: March 15, 2015
  • DOI: 10.17795/jjhr-28714

To Cite: Cheraghi F, Modaress Gilani M, Ghaemmaghami F, Mousavi A. The Five-Year Survival of Patients With Endometrioid-Type Endometrial Cancer, Jundishapur J Helath Res. 2015 ;6(6):e28714. doi: 10.17795/jjhr-28714.

Abstract
Copyright: Copyright © 0, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2): 71-96[DOI][PubMed]
  • 2. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006; 95 Suppl 1-43[DOI][PubMed]
  • 3. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol. 2003; 89(2): 201-9[PubMed]
  • 4. Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg. 2004; 199(3): 388-93[DOI][PubMed]
  • 5. Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004; 95(3): 463-8[DOI][PubMed]
  • 6. Ben-Shachar I, Pavelka J, Cohn DE, Copeland LJ, Ramirez N, Manolitsas T, et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol. 2005; 105(3): 487-93[DOI][PubMed]
  • 7. Roland PY, Kelly FJ, Kulwicki CY, Blitzer P, Curcio M, Orr JW. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol Oncol. 2004; 93(1): 125-30[DOI][PubMed]
  • 8. Cornelison TL, Trimble EL, Kosary CL. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol Oncol. 1999; 74(3): 350-5[DOI][PubMed]
  • 9. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008; 100(23): 1707-16[DOI][PubMed]
  • 10. Pitson G, Colgan T, Levin W, Lockwood G, Manchul L, Milosevic M, et al. Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients. Int J Radiat Oncol Biol Phys. 2002; 53(4): 862-7[PubMed]
  • 11. Blake P, Lodge N, A'Hern RP. An audit of outcome of adjuvant post-operative radiotherapy for 52 women with stage II carcinoma of the endometrium. Br J Radiol. 2000; 73(873): 987-93[DOI][PubMed]
  • 12. Calvin DP, Connell PP, Rotmensch J, Waggoner S, Mundt AJ. Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol. 1999; 22(4): 338-43[PubMed]
  • 13. Greven KM, Corn BW, Case D, Purser P, Lanciano RM. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation? Int J Radiat Oncol Biol Phys. 1997; 39(2): 413-8[PubMed]
  • 14. Descamps P, Calais G, Moire C, Bertrand P, Castiel M, Le Floch O, et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol Oncol. 1997; 64(1): 54-8[DOI][PubMed]
  • 15. Lanciano RM, Curran WJ, Greven KM, Fanning J, Stafford P, Randall ME, et al. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol. 1990; 39(3): 368-73[PubMed]
  • 16. Annual report on the rsults of treatment Gynecological cancer. Journal of Epidemiology and Biostatistics. 2001; 6(1): 1-2
  • 17. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol. 1980; 56(4): 419-27[PubMed]
  • 18. Meerwaldt JH, Hoekstra CJ, van Putten WL, Tjokrowardojo AJ, Koper PC. Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors. Int J Radiat Oncol Biol Phys. 1990; 18(2): 299-304[PubMed]
  • 19. Genest P, Drouin P, Gerig L, Girard A, Stewart D, Prefontaine M. Prognostic factors in early carcinoma of the endometrium. Am J Clin Oncol. 1987; 10(1): 71-7[PubMed]
  • 20. Fujimoto T, Nanjyo H, Fukuda J, Nakamura A, Mizunuma H, Yaegashi N, et al. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence. Gynecol Oncol. 2009; 112(2): 342-7[DOI][PubMed]
  • 21. Grigsby PW, Perez CA, Kuten A, Simpson JR, Garcia DM, Camel HM, et al. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys. 1992; 22(5): 905-11[PubMed]
  • 22. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, van den Bergh AC, de Winter KA, Koper PC, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol. 2004; 22(7): 1234-41[DOI][PubMed]
  • 23. Huh WK, Straughn JM, Kelly FJ, Kilgore LC. Endometrial carcinoma. Curr Treat Options Oncol. 2001; 2(2): 129-35[PubMed]
  • 24. Aalders JG, Thomas G. Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol. 2007; 104(1): 222-31[DOI][PubMed]
  • 25. Mariani A, Dowdy SC, Keeney GL, Haddock MG, Lesnick TG, Podratz KC. Predictors of vaginal relapse in stage I endometrial cancer. Gynecol Oncol. 2005; 97(3): 820-7[DOI][PubMed]
  • 26. Abeler VM, Kjorstad KE, Berle E. Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population. Int J Gynecol Cancer. 1992; 2(1): 9-22[PubMed]
  • 27. Ambros RA, Kurman RJ. Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecol Oncol. 1992; 45(3): 235-9[PubMed]
  • 28. Campagnutta E, Giorda G, De Piero G, Sopracordevole F, Visentin MC, Martella L, et al. Surgical treatment of recurrent endometrial carcinoma. Cancer. 2004; 100(1): 89-96[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader